Aceso Life Science seeks Hong Kong exchange trading resumption from Aug. 14

• Aceso Life Science Group (00474) applied to resume share trading on the Stock Exchange of Hong Kong from 9:00 a.m. Aug. 14.
• Request followed publication of its 2026 annual results on Aug. 13.
• Trading had been suspended due to a delay in releasing the 2026 annual results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260813-12283537), on August 13, 2026, and is solely responsible for the information contained therein.